Enhanced Biochemical Scaffolds for Cognitive Function and Mental Acuity

Publication ID: 24-11857626_0006_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Biochemical Scaffolds for Cognitive Function and Mental Acuity,” Published Technical Disclosure No. 24-11857626_0006_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857626_0006_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,626.

Summary of the Inventive Concept

The present inventive concept relates to novel biochemical scaffolds and associated methods for enhancing cognitive function and mental acuity, building upon the foundation of the original patent by introducing structured water, vibrational energy, and optimized bioactive compounds to improve efficacy and efficiency.

Background and Problem Solved

The original patent disclosed a method of enhancing mental function and acuity by delivering biochemical scaffolds. However, the existing approach has limitations in terms of bioavailability, efficacy, and specificity. The new inventive concept addresses these limitations by incorporating advanced structured water, vibrational energy programming, and optimized bioactive compounds to create more effective and efficient biochemical scaffolds.

Detailed Description of the Inventive Concept

The new inventive concept comprises biochemical scaffolds with structured water content of at least 80%, processed to have a hydrogen bond angle of at least 113°, and further comprising bioactive compounds such as glycerin-based water, waterhyssop, gotu kola, lion's mane mushroom, and ginger root. Additionally, the inventive concept includes a vibrational energy platform to program the biochemical scaffold composition with a specific energetic signature, and optimized ratios of huperzine A and phosphatidylserine. The composition can be formulated to have a pH level of between 7.2 and 7.8, and packaged in single-dose containers with a volume of at least 30 mL.

Novelty and Inventive Step

The new inventive concept introduces the use of structured water, vibrational energy programming, and optimized bioactive compounds, which are not present in the original patent. These advancements provide a significant improvement in efficacy, efficiency, and specificity, making the new inventive concept novel and non-obvious over the prior art.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include varying the ratio of bioactive compounds, using different types of structured water, or incorporating additional vibrational energy frequencies. Variations may also include different methods of administration, such as oral, topical, or injectable forms.

Potential Commercial Applications and Market

The enhanced biochemical scaffolds have significant commercial potential in the cognitive health and wellness industry, with applications in improving focus, concentration, memory recall, and reducing mental fatigue. The target market includes individuals seeking to improve their mental acuity, athletes, and professionals in high-pressure industries.

CPC Classifications

SectionClassGroup
A A61 A61K41/0004
A A61 A61K31/197
A A61 A61K31/4188
A A61 A61K31/4415
A A61 A61K31/455
A A61 A61K31/51
A A61 A61K31/519
A A61 A61K31/525
A A61 A61K31/661
A A61 A61K31/714
A A61 A61K36/06
A A61 A61K36/23
A A61 A61K36/68
A A61 A61K36/9068

Field of Art

Pharmaceutical and nutraceutical compositions for cognitive enhancement, specifically focused on biochemical scaffolds and neurological supplement formulations with expertise in pharmacological ingredient interactions, bioavailability, and neurological function modulation

Person of Ordinary Skill (PHOSITA) Profile

A professional with advanced degrees in pharmacology, biochemistry, or neuroscience, possessing knowledge of herbal supplement design, understanding of bioactive compound interactions, and experience in developing cognitive enhancement formulations

Obviousness Rationale

A person having ordinary skill would recognize that the PTD represents predictable variations on the source patent's core cognitive enhancement composition by introducing incremental modifications such as structured water, vibrational energy programming, and optimized compound ratios that are consistent with known techniques in biochemical supplement design. These variations represent logical extensions of the original patent's methodology, utilizing standard pharmaceutical engineering approaches to improve bioavailability and efficacy. The technical modifications demonstrate routine optimization rather than non-obvious innovation.

Obvious Combinations & Variations

Source Patent Element
Liquid composition with glycerin-based water and herbal compounds
PTD Variation
Structured water with hydrogen bond angle modification and specific pH range
Obviousness Reasoning
Modifying water structure is a known technique in pharmaceutical formulation for improving compound absorption and bioavailability, representing a predictable design choice for a skilled practitioner
Source Patent Element
Cognitive enhancement composition with herbal extracts
PTD Variation
Addition of vibrational energy programming to biochemical scaffold
Obviousness Reasoning
Implementing energetic signature programming is a recognized method for potentially enhancing compound interaction, representing an incremental improvement within standard supplement design practices
Source Patent Element
Specific ranges of herbal and vitamin compounds
PTD Variation
Optimized ratios of huperzine A and phosphatidylserine
Obviousness Reasoning
Adjusting compound ratios to improve efficacy is a standard pharmaceutical engineering approach, demonstrating predictable optimization within known compositional parameters
Source Patent Element
Mental function enhancement method using botanical extracts
PTD Variation
Single-dose container with specific volume and bioavailability considerations
Obviousness Reasoning
Packaging and bioavailability optimization represents routine pharmaceutical design choices that a skilled practitioner would find obvious when improving supplement delivery mechanisms
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the variations disclosed in this Published Technical Disclosure (PTD) render obvious any subsequent patent claims covering cognitive enhancement compositions substantially similar to US Patent 11857626, by demonstrating that the claimed innovations represent predictable variations employing known pharmaceutical engineering techniques to incrementally improve biochemical scaffold design and efficacy.

Original Patent Information

Patent NumberUS 11,857,626
TitleMethod of enhancing mental function and acuity by delivering biochemical scaffolds
Assignee(s)Next2Me, LLC